Managing critically Ill hematology patients: Time to think differently

Area of Science:

• Critical care medicine
• Hematology
• Oncology

Background:

• Increasing incidence of hematological malignancies (HMs) leading to more critically ill patients.
• Effective treatments for HMs improve survival but increase risks of life-threatening complications.
• Rising numbers of HM patients admitted to the Intensive Care Unit (ICU) over the past two decades.

Purpose of the Study:

• To review the diagnostic and therapeutic management of critically ill patients with HMs.
• To discuss the evolving outcomes and determinants of mortality in this patient population.
• To share clinical experience in managing complex HM cases in the ICU.

Main Methods:

• Review of current literature and clinical practices for HM patients in the ICU.
• Analysis of diagnostic workup strategies for organ dysfunction in HM patients.
• Discussion of optimal Intensive Care Unit (ICU) treatments and interventions.

Main Results:

• A sharp decline in mortality rates for HM patients admitted to the ICU.
• Identification of key factors influencing organ dysfunction and critical illness in HM patients.
• Mortality for Acute Respiratory Distress Syndrome (ARDS) or septic shock remains high, up to 50%.

Conclusions:

• Outcomes for critically ill HM patients have significantly improved over time.
• Many traditional mortality predictors in this group are becoming less relevant.
• Optimized diagnostic and therapeutic management is crucial for improving survival in HM patients.